Division of Cardiovascular Medicine, The Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY, United States of America.
Department of Veterans Affairs Medical Center, Lexington, Kentucky, United States of America.
PLoS One. 2019 Feb 7;14(2):e0208099. doi: 10.1371/journal.pone.0208099. eCollection 2019.
Autotaxin (ATX) is a secreted enzyme that generates the bioactive lipid lysophosphatidic acid (LPA). We generated mice with global inducible post-natal inactivation or adipose-specific loss of the Enpp2 gene encoding ATX. The animals are phenotypically unremarkable and exhibit differences in adipocyte size and adipose tissue expression of inflammatory genes after high fat feeding without gross differences in fat distribution or body mass. Surprisingly, both models of Enpp2- deficiency exhibited marked protection from high fat diet-induced hepatic steatosis. This phenotype was not associated with differences in dietary fat absorption but may be accounted for by differences in hepatic expression of genes involved in de novo synthesis of triglycerides. These findings suggest that pharmacological inhibition of ATX might be protective against hepatic steatosis.
自分泌酶(Autotaxin,ATX)是一种分泌型酶,能够生成生物活性脂质溶血磷脂酸(LPA)。我们构建了 Enpp2 基因(编码 ATX)全身性诱导性出生后失活或脂肪组织特异性敲除的小鼠模型。这些动物表型无明显异常,在高脂肪喂养后表现出脂肪细胞大小和脂肪组织炎症基因表达的差异,但脂肪分布或体重无明显差异。令人惊讶的是,Enpp2 基因缺失的两种模型均对高脂肪饮食诱导的肝脂肪变性有明显的保护作用。这种表型与膳食脂肪吸收的差异无关,但可能与参与甘油三酯从头合成的基因在肝脏中的表达差异有关。这些发现表明,ATX 的药理学抑制可能对肝脂肪变性具有保护作用。